<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Wiskott-Aldrich Syndrome - Clinical Decision Support</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            line-height: 1.6;
            color: #333;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            min-height: 100vh;
        }

        .container {
            max-width: 1400px;
            margin: 0 auto;
            display: flex;
            gap: 20px;
            padding: 20px;
        }

        .main-content {
            flex: 1;
            background: white;
            border-radius: 20px;
            box-shadow: 0 20px 60px rgba(0,0,0,0.3);
            overflow: hidden;
        }

        .header {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 30px;
            text-align: center;
        }

        .header h1 {
            font-size: 2.5rem;
            margin-bottom: 10px;
        }

        .header p {
            font-size: 1.1rem;
            opacity: 0.9;
        }

        .section {
            padding: 30px;
            border-bottom: 2px solid #f0f0f0;
        }

        .section:last-child {
            border-bottom: none;
        }

        .card {
            background: white;
            border-radius: 15px;
            border-left: 6px solid;
            margin-bottom: 20px;
            box-shadow: 0 10px 30px rgba(0,0,0,0.1);
            transform: translateY(0);
            transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
            overflow: hidden;
        }

        .card:hover {
            transform: translateY(-5px);
            box-shadow: 0 15px 40px rgba(0,0,0,0.15);
        }

        .card-header {
            display: flex;
            align-items: center;
            padding: 25px;
            cursor: pointer;
            user-select: none;
        }

        .card-icon {
            font-size: 2.5rem;
            margin-right: 20px;
            width: 60px;
            height: 60px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 12px;
        }

        .card-title {
            flex: 1;
        }

        .card-title h2 {
            font-size: 1.8rem;
            margin-bottom: 5px;
        }

        .card-title p {
            color: #666;
            font-size: 0.95rem;
        }

        .expand-icon {
            font-size: 1.5rem;
            transition: transform 0.3s ease;
        }

        .card.expanded .expand-icon {
            transform: rotate(180deg);
        }

        .card-content {
            max-height: 0;
            overflow: hidden;
            transition: max-height 0.5s cubic-bezier(0.4, 0, 0.2, 1);
        }

        .card.expanded .card-content {
            max-height: 2000px;
        }

        .card-inner {
            padding: 0 25px 25px 25px;
        }

        .sub-section {
            margin-bottom: 25px;
        }

        .sub-section h3 {
            color: #4b5563;
            margin-bottom: 15px;
            font-size: 1.3rem;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .sub-section ul {
            list-style: none;
            padding-left: 0;
        }

        .sub-section li {
            padding: 10px 0;
            border-bottom: 1px solid #f3f4f6;
            display: flex;
            align-items: flex-start;
            gap: 10px;
        }

        .sub-section li:last-child {
            border-bottom: none;
        }

        .sub-section li strong {
            color: #1f2937;
        }

        .badge {
            display: inline-block;
            padding: 4px 12px;
            border-radius: 20px;
            font-size: 0.8rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.5px;
            margin-left: 10px;
        }

        .badge-red {
            background: linear-gradient(135deg, #ef4444 0%, #dc2626 100%);
            color: white;
        }

        .badge-amber {
            background: linear-gradient(135deg, #f59e0b 0%, #d97706 100%);
            color: white;
        }

        .badge-green {
            background: linear-gradient(135deg, #10b981 0%, #059669 100%);
            color: white;
        }

        .assessment-card {
            border-left-color: #3b82f6;
        }

        .assessment-card .card-icon {
            background: linear-gradient(135deg, #3b82f6 0%, #2563eb 100%);
            color: white;
        }

        .diagnosis-card {
            border-left-color: #8b5cf6;
        }

        .diagnosis-card .card-icon {
            background: linear-gradient(135deg, #8b5cf6 0%, #7c3aed 100%);
            color: white;
        }

        .treatment-card {
            border-left-color: #10b981;
        }

        .treatment-card .card-icon {
            background: linear-gradient(135deg, #10b981 0%, #059669 100%);
            color: white;
        }

        .followup-card {
            border-left-color: #f59e0b;
        }

        .followup-card .card-icon {
            background: linear-gradient(135deg, #f59e0b 0%, #d97706 100%);
            color: white;
        }

        .pathway-container {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 20px;
            margin-bottom: 20px;
        }

        .pathway-box {
            background: linear-gradient(135deg, #f8fafc 0%, #e2e8f0 100%);
            border-radius: 12px;
            padding: 20px;
            border: 2px solid #e2e8f0;
            transition: all 0.3s ease;
        }

        .pathway-box:hover {
            border-color: #94a3b8;
            transform: translateY(-2px);
        }

        .pathway-title {
            font-weight: bold;
            font-size: 1.2rem;
            margin-bottom: 15px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .nested-card {
            background: white;
            border-radius: 10px;
            padding: 20px;
            margin-bottom: 15px;
            border-left: 4px solid #e5e7eb;
            transition: all 0.3s ease;
        }

        .nested-card:hover {
            border-left-color: #3b82f6;
            box-shadow: 0 5px 15px rgba(0,0,0,0.1);
        }

        .sidebar {
            width: 300px;
            position: sticky;
            top: 20px;
            height: fit-content;
        }

        .progress-card {
            background: white;
            border-radius: 15px;
            box-shadow: 0 10px 30px rgba(0,0,0,0.1);
            overflow: hidden;
        }

        .progress-header {
            background: linear-gradient(135deg, #4f46e5 0%, #7c3aed 100%);
            color: white;
            padding: 20px;
            font-size: 1.2rem;
            font-weight: bold;
        }

        .progress-item {
            padding: 15px 20px;
            display: flex;
            align-items: center;
            gap: 12px;
            cursor: pointer;
            transition: all 0.3s ease;
            border-left: 4px solid transparent;
        }

        .progress-item.active {
            background: #f0f9ff;
            border-left-color: #3b82f6;
            color: #1d4ed8;
            font-weight: 600;
        }

        .progress-item.completed {
            background: #f0fdf4;
            border-left-color: #10b981;
        }

        .progress-icon {
            width: 24px;
            height: 24px;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 0.8rem;
        }

        .progress-item.active .progress-icon {
            background: #3b82f6;
            color: white;
        }

        .progress-item.completed .progress-icon {
            background: #10b981;
            color: white;
        }

        .progress-item:not(.active):not(.completed) .progress-icon {
            background: #e5e7eb;
            color: #9ca3af;
        }

        .progress-title {
            font-size: 0.95rem;
        }

        .progress-percentage {
            margin-left: auto;
            font-size: 0.8rem;
            color: #6b7280;
        }

        .alert-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fde68a 100%);
            border: 1px solid #f59e0b;
            border-radius: 10px;
            padding: 15px;
            margin-bottom: 20px;
            display: flex;
            align-items: flex-start;
            gap: 15px;
        }

        .alert-icon {
            color: #f59e0b;
            font-size: 1.5rem;
        }

        .alert-content h4 {
            color: #92400e;
            margin-bottom: 5px;
        }

        .alert-content p {
            color: #92400e;
            font-size: 0.95rem;
        }

        .treatment-grid {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 15px;
        }

        .treatment-item {
            background: #f9fafb;
            padding: 15px;
            border-radius: 8px;
            border-left: 4px solid #3b82f6;
        }

        .treatment-item h4 {
            color: #1f2937;
            margin-bottom: 8px;
            font-size: 1rem;
        }

        .treatment-item p {
            font-size: 0.9rem;
            color: #4b5563;
        }

        .btn {
            background: linear-gradient(135deg, #3b82f6 0%, #2563eb 100%);
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.3s ease;
            margin-top: 15px;
        }

        .btn:hover {
            transform: translateY(-2px);
            box-shadow: 0 5px 15px rgba(59, 130, 246, 0.3);
        }

        .reference-box {
            background: #f8fafc;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            padding: 15px;
            margin-top: 15px;
        }

        .reference-box h4 {
            color: #374151;
            margin-bottom: 10px;
            font-size: 1rem;
        }

        .reference-box p {
            font-size: 0.85rem;
            color: #6b7280;
            line-height: 1.5;
        }

        @media print {
            body {
                background: white;
            }
            .sidebar, .btn, .expand-icon {
                display: none;
            }
            .card {
                box-shadow: none !important;
                page-break-inside: avoid;
            }
            .card-content {
                max-height: none !important;
            }
        }

        @media (max-width: 1024px) {
            .container {
                flex-direction: column;
            }
            .sidebar {
                width: 100%;
                position: relative;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="main-content">
            <div class="header">
                <h1><i class="fas fa-dna"></i> Wiskott-Aldrich Syndrome</h1>
                <p>Clinical Decision Support Algorithm | BMJ Best Practice Guidelines</p>
            </div>

            <!-- Assessment Section -->
            <div class="section" id="assessment-section">
                <div class="card assessment-card" data-section="assessment">
                    <div class="card-header" onclick="toggleCard(this)">
                        <div class="card-icon">
                            <i class="fas fa-stethoscope"></i>
                        </div>
                        <div class="card-title">
                            <h2>Assessment</h2>
                            <p>Clinical evaluation and initial presentation assessment</p>
                        </div>
                        <div class="expand-icon">
                            <i class="fas fa-chevron-down"></i>
                        </div>
                    </div>
                    <div class="card-content">
                        <div class="card-inner">
                            <div class="alert-box">
                                <div class="alert-icon">
                                    <i class="fas fa-exclamation-triangle"></i>
                                </div>
                                <div class="alert-content">
                                    <h4>Key Presentation Features</h4>
                                    <p>Thrombocytopenia is universal at birth. Eczema and immunodeficiency develop variably over time.</p>
                                </div>
                            </div>

                            <div class="sub-section">
                                <h3><i class="fas fa-check-circle"></i> Key Diagnostic Factors</h3>
                                <ul>
                                    <li>
                                        <i class="fas fa-users text-blue-500"></i>
                                        <strong>Family history of WAS</strong>
                                        <span class="badge badge-amber">Common</span>
                                        <p class="text-sm text-gray-600">Diagnosis may be suspected if there is a family history of thrombocytopenia, bleeding problems, or male infant deaths.</p>
                                    </li>
                                    <li>
                                        <i class="fas fa-tint text-red-500"></i>
                                        <strong>Easy bruising and petechiae</strong>
                                        <span class="badge badge-amber">Common</span>
                                        <p class="text-sm text-gray-600">Extent depends on degree of thrombocytopenia.</p>
                                    </li>
                                    <li>
                                        <i class="fas fa-shield-alt text-blue-500"></i>
                                        <strong>Recurrent infections</strong>
                                        <span class="badge badge-amber">Common</span>
                                        <p class="text-sm text-gray-600">Most often ear and respiratory infections.</p>
                                    </li>
                                    <li>
                                        <i class="fas fa-hand-holding-medical text-purple-500"></i>
                                        <strong>Eczema</strong>
                                        <span class="badge badge-amber">Common</span>
                                        <p class="text-sm text-gray-600">Variable severity. Often generalized if moderate or severe.</p>
                                    </li>
                                </ul>
                            </div>

                            <div class="sub-section">
                                <h3><i class="fas fa-info-circle"></i> Other Diagnostic Factors</h3>
                                <ul>
                                    <li><i class="fas fa-search"></i> <strong>Bruises and petechiae</strong> - Petechiae or bleeding often seen at sites of excoriation</li>
                                    <li><i class="fas fa-project-diagram"></i> <strong>Lymphadenopathy</strong> - May be present, particularly if skin is inflamed</li>
                                    <li><i class="fas fa-ear-listen"></i> <strong>Perforated tympanic membranes</strong> - Associated with past and current infections</li>
                                    <li><i class="fas fa-exclamation text-red-500"></i> <strong>Serious bleeding</strong> <span class="badge badge-red">Uncommon</span> - Can be spontaneous or post-traumatic</li>
                                    <li><i class="fas fa-virus text-red-500"></i> <strong>Serious/life-threatening infection</strong> <span class="badge badge-red">Uncommon</span></li>
                                    <li><i class="fas fa-atom text-purple-500"></i> <strong>Autoimmunity</strong> <span class="badge badge-amber">Uncommon</span> - Affects 26-72% of individuals at some point</li>
                                </ul>
                            </div>

                            <div class="sub-section">
                                <h3><i class="fas fa-exclamation-triangle"></i> Risk Factors</h3>
                                <ul>
                                    <li>
                                        <i class="fas fa-female text-pink-500"></i>
                                        <strong>Maternal WAS gene mutation carrier</strong>
                                        <span class="badge badge-red">Strong</span>
                                        <p class="text-sm text-gray-600">WAS is inherited in an X-linked manner.</p>
                                    </li>
                                    <li>
                                        <i class="fas fa-male text-blue-500"></i>
                                        <strong>Male sex</strong>
                                        <span class="badge badge-red">Strong</span>
                                        <p class="text-sm text-gray-600">Primarily affects males due to X-linked inheritance.</p>
                                    </li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Diagnosis Section -->
            <div class="section" id="diagnosis-section">
                <div class="card diagnosis-card" data-section="diagnosis">
                    <div class="card-header" onclick="toggleCard(this)">
                        <div class="card-icon">
                            <i class="fas fa-microscope"></i>
                        </div>
                        <div class="card-title">
                            <h2>Diagnosis</h2>
                            <p>Investigations and diagnostic criteria</p>
                        </div>
                        <div class="expand-icon">
                            <i class="fas fa-chevron-down"></i>
                        </div>
                    </div>
                    <div class="card-content">
                        <div class="card-inner">
                            <div class="alert-box">
                                <div class="alert-icon">
                                    <i class="fas fa-info-circle"></i>
                                </div>
                                <div class="alert-content">
                                    <h4>Definitive Diagnosis</h4>
                                    <p>WAS protein (WASp) gene mutation analysis is the definitive test for diagnosis.</p>
                                </div>
                            </div>

                            <div class="sub-section">
                                <h3><i class="fas fa-vial"></i> Initial Diagnostic Investigations</h3>
                                <div class="treatment-grid">
                                    <div class="treatment-item">
                                        <h4>FBC with platelet volume <span class="badge badge-red">Essential</span></h4>
                                        <p>Thrombocytopenia with small platelet volume is universal unless splenectomy has been performed.</p>
                                    </div>
                                    <div class="treatment-item">
                                        <h4>WAS protein (WASp) analysis <span class="badge badge-amber">Specialized</span></h4>
                                        <p>Performed by Western blot, flow cytometry, or fluorescence-activated cell sorter. Available at selected centers.</p>
                                    </div>
                                    <div class="treatment-item">
                                        <h4>WAS protein (WASp) gene mutation analysis <span class="badge badge-red">Definitive</span></h4>
                                        <p>Sequence analysis for mutation in the WASp gene detects mutations in ~99% of affected males.</p>
                                    </div>
                                    <div class="treatment-item">
                                        <h4>Pre-treatment baseline tests</h4>
                                        <p>Liver function tests, Hepatitis C PCR, EBV/CMV PCR, and serum storage for future analysis.</p>
                                    </div>
                                </div>
                            </div>

                            <div class="sub-section">
                                <h3><i class="fas fa-search-plus"></i> Subsequent Investigations</h3>
                                <ul>
                                    <li><i class="fas fa-shield-alt"></i> <strong>Immunoglobulin levels</strong> - Extremely variable: often normal IgG; raised IgA; low IgM in older patients</li>
                                    <li><i class="fas fa-syringe"></i> <strong>Vaccine responses</strong> - May have normal or low responses to protein antigens, more commonly low antibodies to polysaccharide antigens</li>
                                    <li><i class="fas fa-tint"></i> <strong>Isohaemagglutinins</strong> - Commonly low</li>
                                    <li><i class="fas fa-cells"></i> <strong>Lymphocyte subsets</strong> - Classically low CD8 T-cell levels</li>
                                    <li><i class="fas fa-flask"></i> <strong>T-cell proliferation assays</strong> - Classically low anti-CD3 stimulation</li>
                                </ul>
                            </div>

                            <div class="sub-section">
                                <h3><i class="fas fa-not-equal"></i> Differential Diagnoses</h3>
                                <div class="nested-card">
                                    <h4><i class="fas fa-search"></i> Idiopathic Thrombocytopenia (ITP)</h4>
                                    <p><strong>Differentiating features:</strong> Unlike WAS, ITP is not present from birth and is not familial. Platelet size is below normal range in WAS.</p>
                                    <p><strong>Test:</strong> Evidence of autoimmune basis is not a discriminator, as this can be present in WAS too.</p>
                                </div>
                                <div class="nested-card">
                                    <h4><i class="fas fa-project-diagram"></i> Autoimmune Lymphoproliferative Syndrome (ALPS)</h4>
                                    <p><strong>Differentiating features:</strong> ALPS is usually associated with more striking generalized lymphadenopathy than seen in WAS.</p>
                                    <p><strong>Test:</strong> Double negative T-cells are raised in ALPS and normal in WAS.</p>
                                </div>
                            </div>

                            <div class="sub-section">
                                <h3><i class="fas fa-layer-group"></i> Clinical Classification</h3>
                                <div class="pathway-container">
                                    <div class="pathway-box">
                                        <div class="pathway-title">
                                            <i class="fas fa-exclamation-triangle text-red-500"></i>
                                            Severe WAS
                                        </div>
                                        <p>Severe clinical course with significant morbidity and mortality without curative bone marrow transplantation.</p>
                                        <p><strong>Genetics:</strong> Mutations resulting in absent protein product.</p>
                                        <span class="badge badge-red">High Risk</span>
                                    </div>
                                    <div class="pathway-box">
                                        <div class="pathway-title">
                                            <i class="fas fa-check-circle text-green-500"></i>
                                            Attenuated WAS (X-linked thrombocytopenia)
                                        </div>
                                        <p>Milder clinical course with good prognosis.</p>
                                        <p><strong>Genetics:</strong> Mutations preserving reduced protein product.</p>
                                        <span class="badge badge-green">Better Outlook</span>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Treatment Section -->
            <div class="section" id="treatment-section">
                <div class="card treatment-card" data-section="treatment">
                    <div class="card-header" onclick="toggleCard(this)">
                        <div class="card-icon">
                            <i class="fas fa-heartbeat"></i>
                        </div>
                        <div class="card-title">
                            <h2>Treatment</h2>
                            <p>Management pathways and therapeutic interventions</p>
                        </div>
                        <div class="expand-icon">
                            <i class="fas fa-chevron-down"></i>
                        </div>
                    </div>
                    <div class="card-content">
                        <div class="card-inner">
                            <div class="alert-box">
                                <div class="alert-icon">
                                    <i class="fas fa-lightbulb"></i>
                                </div>
                                <div class="alert-content">
                                    <h4>Treatment Approach</h4>
                                    <p>Management differs significantly between attenuated and severe WAS. HSCT is curative for severe disease.</p>
                                </div>
                            </div>

                            <div class="sub-section">
                                <h3><i class="fas fa-route"></i> Treatment Pathways</h3>
                                <div class="pathway-container">
                                    <div class="pathway-box">
                                        <div class="pathway-title">
                                            <i class="fas fa-user-check text-green-500"></i>
                                            Attenuated WAS
                                        </div>
                                        <p>Observation and symptom-based management. No treatment required if asymptomatic.</p>
                                        <p><strong>Key interventions:</strong> Prophylactic antibiotics, immunoglobulin if needed, eczema management, bleeding control.</p>
                                        <span class="badge badge-green">Conservative</span>
                                    </div>
                                    <div class="pathway-box">
                                        <div class="pathway-title">
                                            <i class="fas fa-hospital text-red-500"></i>
                                            Severe Classical WAS
                                        </div>
                                        <p>Optimal prophylactic treatment until curative HSCT is available.</p>
                                        <p><strong>Key interventions:</strong> Prophylactic antibiotics, immunoglobulin, HSCT when donor available.</p>
                                        <span class="badge badge-red">Curative Intent</span>
                                    </div>
                                </div>
                            </div>

                            <div class="sub-section">
                                <h3><i class="fas fa-pills"></i> Specific Management Areas</h3>
                                
                                <div class="nested-card">
                                    <h4><i class="fas fa-lungs-virus"></i> Infection Prophylaxis <span class="badge badge-amber">Essential</span></h4>
                                    <div class="treatment-grid">
                                        <div class="treatment-item">
                                            <h4>Prophylactic Antibiotics</h4>
                                            <p><strong>First-line:</strong> Trimethoprim/sulfamethoxazole 2.5 mg/kg twice daily</p>
                                            <p><strong>Alternative:</strong> Azithromycin 10 mg/kg once daily for 3 days every 14 days</p>
                                        </div>
                                        <div class="treatment-item">
                                            <h4>Immunoglobulin Replacement</h4>
                                            <p>Indicated for frequent/severe infections or abnormal vaccine responses.</p>
                                            <p>Subcutaneous administration is well-tolerated and facilitates home care.</p>
                                        </div>
                                    </div>
                                </div>

                                <div class="nested-card">
                                    <h4><i class="fas fa-hand-holding-medical"></i> Eczema Management <span class="badge badge-amber">Symptom Control</span></h4>
                                    <p>Step-wise approach similar to atopic eczema, but often requires rapid progression to stronger treatments.</p>
                                    <ol class="list-decimal list-inside space-y-2 text-sm">
                                        <li><strong>Emollients</strong> - First-line with bath emollients and soap substitutes</li>
                                        <li><strong>Topical corticosteroids</strong> - Mild to moderate strength depending on severity</li>
                                        <li><strong>Topical tacrolimus</strong> - Corticosteroid-sparing agent for children >2 years</li>
                                        <li><strong>Systemic corticosteroids</strong> - Prednisolone 1 mg/kg/day for severe cases</li>
                                    </ol>
                                    <div class="reference-box">
                                        <h4>Dermatology Referral</h4>
                                        <p>Early referral recommended as WAS-related eczema often responds suboptimally to standard treatment.</p>
                                    </div>
                                </div>

                                <div class="nested-card">
                                    <h4><i class="fas fa-tint"></i> Bleeding and Bruising Management <span class="badge badge-red">Critical</span></h4>
                                    <p>Goal: Prevention of serious bleeding episodes (intracranial, gastrointestinal).</p>
                                    <div class="treatment-grid">
                                        <div class="treatment-item">
                                            <h4>Acute Bleeding</h4>
                                            <p><strong>Aminocaproic acid:</strong> 100-200 mg/kg loading dose, then 100 mg/kg every 4-6 hours</p>
                                            <p><strong>Platelet transfusion:</strong> First-line treatment, check increment</p>
                                        </div>
                                        <div class="treatment-item">
                                            <h4>Refractory Bleeding</h4>
                                            <p><strong>Combination therapy:</strong></p>
                                            <ul class="text-sm">
                                                <li>Systemic corticosteroids (2 mg/kg/day)</li>
                                                <li>High-dose immunoglobulin</li>
                                                <li>Rituximab (anti-CD20)</li>
                                            </ul>
                                        </div>
                                    </div>
                                    <div class="alert-box">
                                        <div class="alert-icon">
                                            <i class="fas fa-exclamation-triangle text-red-500"></i>
                                        </div>
                                        <div class="alert-content">
                                            <h4>Urgent Assessment Required</h4>
                                            <p>Mucosal bleeding (mouth/rectal) or significant trauma, especially head injury, requires urgent evaluation.</p>
                                        </div>
                                    </div>
                                </div>

                                <div class="nested-card">
                                    <h4><i class="fas fa-atom"></i> Autoimmunity Management <span class="badge badge-red">Reclassifies to Severe</span></h4>
                                    <p>Development of autoimmunity automatically classifies patient as severe WAS - consider HSCT.</p>
                                    <ul class="list-disc list-inside space-y-2 text-sm">
                                        <li><strong>Autoimmune cytopenias:</strong> Rituximab is generally effective</li>
                                        <li><strong>Vasculitis/Colitis:</strong> Multidisciplinary approach required</li>
                                        <li><strong>All autoimmunity:</strong> Consultant input essential, HSCT assessment indicated</li>
                                    </ul>
                                </div>

                                <div class="nested-card">
                                    <h4><i class="fas fa-heart"></i> Haematopoietic Stem Cell Transplantation <span class="badge badge-red">Curative</span></h4>
                                    <p>HSCT should be performed where a matched sibling or matched unrelated donor is available.</p>
                                    <div class="treatment-grid">
                                        <div class="treatment-item">
                                            <h4>Donor Selection</h4>
                                            <p><strong>Preferred:</strong> Matched sibling or matched unrelated donor</p>
                                            <p><strong>Survival rates:</strong> >90% overall survival</p>
                                            <p><strong>Avoid:</strong> Haploidentical transplant (historically poor outcomes)</p>
                                        </div>
                                        <div class="treatment-item">
                                            <h4>Pre-HSCT Considerations</h4>
                                            <p>Complete infection screening (EBV, CMV, adenovirus PCR)</p>
                                            <p>Document pre-immunoglobulin antibody levels</p>
                                            <p>Continue prophylaxis until successful engraftment</p>
                                        </div>
                                    </div>
                                    <button class="btn" onclick="alert('HSCT timing: Ideally performed early in life before complications develop. Coordinate with specialized transplant center.')">
                                        <i class="fas fa-calendar"></i> HSCT Timing Considerations
                                    </button>
                                </div>

                                <div class="nested-card">
                                    <h4><i class="fas fa-dna"></i> Emerging Therapies</h4>
                                    <ul class="list-disc list-inside space-y-2 text-sm">
                                        <li><strong>Gene Therapy:</strong> Lentiviral hematopoietic stem cell gene therapy in clinical trials</li>
                                        <li><strong>Thrombopoietin receptor agonists:</strong> Eltrombopag may increase platelet counts in some patients</li>
                                    </ul>
                                    <div class="reference-box">
                                        <h4>Available at Specialist Centers</h4>
                                        <p>Gene therapy is an alternative for patients lacking suitable bone marrow donors. Consult specialized centers for trial availability.</p>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Follow-up Section -->
            <div class="section" id="followup-section">
                <div class="card followup-card" data-section="followup">
                    <div class="card-header" onclick="toggleCard(this)">
                        <div class="card-icon">
                            <i class="fas fa-chart-line"></i>
                        </div>
                        <div class="card-title">
                            <h2>Follow-up</h2>
                            <p>Monitoring schedule and long-term prognosis</p>
                        </div>
                        <div class="expand-icon">
                            <i class="fas fa-chevron-down"></i>
                        </div>
                    </div>
                    <div class="card-content">
                        <div class="card-inner">
                            <div class="alert-box">
                                <div class="alert-icon">
                                    <i class="fas fa-calendar-check"></i>
                                </div>
                                <div class="alert-content">
                                    <h4>Monitoring Frequency</h4>
                                    <p>Asymptomatic attenuated WAS: Annual follow-up. Severe/symptomatic: Tailor to clinical need.</p>
                                </div>
                            </div>

                            <div class="sub-section">
                                <h3><i class="fas fa-stethoscope"></i> Monitoring Schedule</h3>
                                <div class="pathway-container">
                                    <div class="pathway-box">
                                        <div class="pathway-title">
                                            <i class="fas fa-user-check text-green-500"></i>
                                            Attenuated WAS (Asymptomatic)
                                        </div>
                                        <ul class="text-sm space-y-2">
                                            <li>Annual clinical monitoring</li>
                                            <li>Check infection, eczema, bleeding history</li>
                                            <li>Annual investigations:
                                                <ul class="ml-4 mt-1">
                                                    <li>Complete blood count</li>
                                                    <li>Immunoglobulin levels (IgG, IgA, IgM)</li>
                                                    <li>Lymphocyte subsets</li>
                                                    <li>Proliferative responses</li>
                                                </ul>
                                            </li>
                                        </ul>
                                        <span class="badge badge-green">Annual</span>
                                    </div>
                                    <div class="pathway-box">
                                        <div class="pathway-title">
                                            <i class="fas fa-hospital text-amber-500"></i>
                                            Severe or Symptomatic WAS
                                        </div>
                                        <ul class="text-sm space-y-2">
                                            <li>Tailor regularity to clinical need</li>
                                            <li>Monitor infections, eczema, bleeding episodes</li>
                                            <li>Check for autoimmunity or suspicious lymphadenopathy</li>
                                            <li>Annual laboratory investigations (as above)</li>
                                            <li>Additional tests as clinically indicated</li>
                                        </ul>
                                        <span class="badge badge-amber">Variable</span>
                                    </div>
                                </div>
                            </div>

                            <div class="sub-section">
                                <h3><i class="fas fa-exclamation-triangle"></i> Complications</h3>
                                <div class="treatment-grid">
                                    <div class="treatment-item">
                                        <h4>Autoimmunity <span class="badge badge-red">High Risk</span></h4>
                                        <p>Affects 26-72% long-term. Wide variety of autoimmune syndromes. Development classifies as severe WAS.</p>
                                    </div>
                                    <div class="treatment-item">
                                        <h4>Eczema <span class="badge badge-amber">High Risk</span></h4>
                                        <p>Variable severity. Usually worse in severe WAS. Early dermatology input recommended.</p>
                                    </div>
                                    <div class="treatment-item">
                                        <h4>Bleeding <span class="badge badge-amber">Medium Risk</span></h4>
                                        <p>Intracranial and GI bleeding are main manifestations. Risk increases with autoimmune thrombocytopenia.</p>
                                    </div>
                                    <div class="treatment-item">
                                        <h4>Infection <span class="badge badge-amber">Medium Risk</span></h4>
                                        <p>Bacterial, fungal, viral, and opportunistic infections. Splenectomy increases sepsis risk significantly.</p>
                                    </div>
                                    <div class="treatment-item">
                                        <h4>Malignancy <span class="badge badge-amber">Medium Risk</span></h4>
                                        <p>Lymphomas and myelodysplastic syndromes complicate 10-20% of cases. Often EBV-driven.</p>
                                    </div>
                                </div>
                            </div>

                            <div class="sub-section">
                                <h3><i class="fas fa-chart-bar"></i> Prognosis</h3>
                                <div class="pathway-container">
                                    <div class="pathway-box">
                                        <div class="pathway-title">
                                            <i class="fas fa-check-circle text-green-500"></i>
                                            Attenuated WAS
                                        </div>
                                        <p>Long-term outlook is believed to be good. Complications include risk of severe bleeding and autoimmunity.</p>
                                        <span class="badge badge-green">Favorable</span>
                                        <div class="reference-box mt-3">
                                            <p class="text-sm">Requires ongoing monitoring for transformation to severe phenotype.</p>
                                        </div>
                                    </div>
                                    <div class="pathway-box">
                                        <div class="pathway-title">
                                            <i class="fas fa-exclamation-triangle text-red-500"></i>
                                            Severe WAS
                                        </div>
                                        <p>Survival into third decade unlikely without transplant. Major causes of mortality: severe bleeding, serious infections, autoimmunity.</p>
                                        <span class="badge badge-red">Poor without HSCT</span>
                                    </div>
                                </div>
                            </div>

                            <div class="sub-section">
                                <h3><i class="fas fa-heart"></i> HSCT Outcomes</h3>
                                <div class="alert-box">
                                    <div class="alert-icon">
                                        <i class="fas fa-heart text-green-500"></i>
                                    </div>
                                    <div class="alert-content">
                                        <h4>Excellent Survival Rates</h4>
                                        <p>Five-year survival rates approach 90% for matched sibling donors and fully matched unrelated donors. Significantly improved over past decade.</p>
                                    </div>
                                </div>
                                <div class="treatment-grid">
                                    <div class="treatment-item">
                                        <h4>Matched Sibling Donor</h4>
                                        <p>~90% overall survival</p>
                                        <span class="badge badge-green">Preferred</span>
                                    </div>
                                    <div class="treatment-item">
                                        <h4>Matched Unrelated Donor</h4>
                                        <p>~90% overall survival</p>
                                        <span class="badge badge-green">Excellent</span>
                                    </div>
                                    <div class="treatment-item">
                                        <h4>Mismatched Family Donor</h4>
                                        <p>Historically 50-55% survival, improving</p>
                                        <span class="badge badge-amber">Avoid if possible</span>
                                    </div>
                                    <div class="treatment-item">
                                        <h4>Haploidentical</h4>
                                        <p>Generally avoided due to poor outcomes</p>
                                        <span class="badge badge-red">Not Recommended</span>
                                    </div>
                                </div>
                            </div>

                            <div class="sub-section">
                                <h3><i class="fas fa-user-md"></i> Patient Education & Red Flags</h3>
                                <div class="nested-card">
                                    <h4>When to Seek Urgent Care</h4>
                                    <ul class="list-disc list-inside space-y-2 text-sm">
                                        <li><strong>Fever without focus:</strong> Seek prompt medical attention (especially severe WAS)</li>
                                        <li><strong>Mucosal bleeding:</strong> Mouth or rectal bleeding requires urgent assessment</li>
                                        <li><strong>Significant trauma:</strong> Especially head injury - always assess after trauma</li>
                                        <li><strong>Clinical deterioration:</strong> Early follow-up if any aspect worsens</li>
                                    </ul>
                                    <div class="alert-box mt-3">
                                        <div class="alert-icon">
                                            <i class="fas fa-sports text-blue-500"></i>
                                        </div>
                                        <div class="alert-content">
                                            <h4>Lifestyle Modifications</h4>
                                            <p>Patients with thrombocytopenia should avoid contact sports. Appropriate malaria prophylaxis required if traveling.</p>
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Progress Sidebar -->
        <div class="sidebar">
            <div class="progress-card">
                <div class="progress-header">
                    <i class="fas fa-compass"></i> Progress
                </div>
                <div class="progress-container">
                    <div class="progress-item active" data-target="assessment-section">
                        <div class="progress-icon">1</div>
                        <div class="progress-title">Assessment</div>
                        <div class="progress-percentage">0%</div>
                    </div>
                    <div class="progress-item" data-target="diagnosis-section">
                        <div class="progress-icon">2</div>
                        <div class="progress-title">Diagnosis</div>
                        <div class="progress-percentage">0%</div>
                    </div>
                    <div class="progress-item" data-target="treatment-section">
                        <div class="progress-icon">3</div>
                        <div class="progress-title">Treatment</div>
                        <div class="progress-percentage">0%</div>
                    </div>
                    <div class="progress-item" data-target="followup-section">
                        <div class="progress-icon">4</div>
                        <div class="progress-title">Follow-up</div>
                        <div class="progress-percentage">0%</div>
                    </div>
                </div>
            </div>
            
            <div class="progress-card mt-4">
                <div class="progress-header">
                    <i class="fas fa-cogs"></i> Quick Actions
                </div>
                <button class="btn w-full text-center" onclick="printAlgorithm()">
                    <i class="fas fa-print"></i> Print Algorithm
                </button>
                <button class="btn w-full text-center mt-3" onclick="resetAlgorithm()">
                    <i class="fas fa-redo"></i> Reset View
                </button>
            </div>

            <div class="progress-card mt-4">
                <div class="progress-header">
                    <i class="fas fa-book"></i> Key References
                </div>
                <div class="p-4 text-sm text-gray-600 space-y-2">
                    <p><strong>Guidelines:</strong> BMJ Best Practice (Apr 2022)</p>
                    <p><strong>HSCT:</strong> PIDTC Report, Blood 2020</p>
                    <p><strong>Gene Therapy:</strong> Science 2013; JAMA 2015</p>
                    <p><strong>Autoimmunity:</strong> Appl Clin Genet 2021</p>
                </div>
            </div>
        </div>
    </div>

    <script>
        // Card expansion functionality
        function toggleCard(header) {
            const card = header.parentElement;
            const sectionId = card.getAttribute('data-section');
            
            card.classList.toggle('expanded');
            
            // Update progress when card is opened
            if (card.classList.contains('expanded')) {
                updateProgress(sectionId, 100);
            }
        }

        // Progress tracking
        let progressState = {
            assessment: 0,
            diagnosis: 0,
            treatment: 0,
            followup: 0
        };

        function updateProgress(section, percentage) {
            progressState[section] = percentage;
            const progressItem = document.querySelector(`[data-target="${section}-section"]`);
            if (progressItem) {
                progressItem.querySelector('.progress-percentage').textContent = percentage + '%';
                
                if (percentage === 100) {
                    progressItem.classList.add('completed');
                    progressItem.classList.remove('active');
                }
            }
        }

        // Smooth scroll to section
        function scrollToSection(sectionId) {
            const section = document.getElementById(sectionId);
            if (section) {
                section.scrollIntoView({ 
                    behavior: 'smooth', 
                    block: 'start' 
                });
                
                // Expand the card in that section
                const card = section.querySelector('.card');
                if (card && !card.classList.contains('expanded')) {
                    card.classList.add('expanded');
                    const sectionName = card.getAttribute('data-section');
                    updateProgress(sectionName, 100);
                }
                
                // Update active state in sidebar
                document.querySelectorAll('.progress-item').forEach(item => {
                    item.classList.remove('active');
                });
                document.querySelector(`[data-target="${sectionId}"]`).classList.add('active');
            }
        }

        // Sidebar navigation
        document.querySelectorAll('.progress-item').forEach(item => {
            item.addEventListener('click', function() {
                const targetId = this.getAttribute('data-target');
                scrollToSection(targetId);
            });
        });

        // Intersection Observer for scroll tracking
        const observerOptions = {
            root: null,
            rootMargin: '-50% 0px -50% 0px',
            threshold: 0
        };

        const observer = new IntersectionObserver((entries) => {
            entries.forEach(entry => {
                if (entry.isIntersecting) {
                    const sectionId = entry.target.id;
                    document.querySelectorAll('.progress-item').forEach(item => {
                        item.classList.remove('active');
                    });
                    const matchingItem = document.querySelector(`[data-target="${sectionId}"]`);
                    if (matchingItem) {
                        matchingItem.classList.add('active');
                    }
                }
            });
        }, observerOptions);

        // Observe all sections
        document.querySelectorAll('.section').forEach(section => {
            observer.observe(section);
        });

        // Print functionality
        function printAlgorithm() {
            window.print();
        }

        // Reset functionality
        function resetAlgorithm() {
            // Collapse all cards
            document.querySelectorAll('.card').forEach(card => {
                card.classList.remove('expanded');
            });
            
            // Reset progress
            Object.keys(progressState).forEach(key => {
                progressState[key] = 0;
                updateProgress(key, 0);
            });
            
            // Reset sidebar
            document.querySelectorAll('.progress-item').forEach(item => {
                item.classList.remove('active', 'completed');
            });
            document.querySelector('[data-target="assessment-section"]').classList.add('active');
            
            // Scroll to top
            window.scrollTo({ top: 0, behavior: 'smooth' });
        }

        // Auto-expand first card on load
        window.addEventListener('load', function() {
            const firstCard = document.querySelector('.card');
            if (firstCard) {
                setTimeout(() => {
                    firstCard.classList.add('expanded');
                    updateProgress('assessment', 100);
                }, 500);
            }
        });

        // Add smooth transitions for all interactive elements
        document.querySelectorAll('.btn, .card-header, .progress-item').forEach(element => {
            element.style.transition = 'all 0.3s cubic-bezier(0.4, 0, 0.2, 1)';
        });

        // Keyboard navigation
        document.addEventListener('keydown', function(e) {
            if (e.key === 'ArrowDown' || e.key === 'ArrowRight') {
                const activeItem = document.querySelector('.progress-item.active');
                const nextItem = activeItem?.nextElementSibling;
                if (nextItem && nextItem.classList.contains('progress-item')) {
                    nextItem.click();
                }
            } else if (e.key === 'ArrowUp' || e.key === 'ArrowLeft') {
                const activeItem = document.querySelector('.progress-item.active');
                const prevItem = activeItem?.previousElementSibling;
                if (prevItem && prevItem.classList.contains('progress-item')) {
                    prevItem.click();
                }
            } else if (e.key === 'Enter' || e.key === ' ') {
                const activeCard = document.querySelector('.card.expanded');
                if (activeCard) {
                    const nextCard = activeCard.closest('.section')?.nextElementSibling?.querySelector('.card');
                    if (nextCard) {
                        scrollToSection(nextCard.closest('.section').id);
                    }
                }
            }
        });

        // Add visual feedback for interactions
        document.querySelectorAll('.btn').forEach(btn => {
            btn.addEventListener('click', function() {
                this.style.transform = 'scale(0.95)';
                setTimeout(() => {
                    this.style.transform = 'scale(1)';
                }, 150);
            });
        });
    </script>
</body>
</html>